Referências
Principais artigos
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed, text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.
National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management. September 2019 [internet publication].Texto completo
Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021 Sep;128:789-818.Texto completo Resumo
Artigos de referência
1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed, text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.
3. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management. September 2019 [internet publication].Texto completo
4. Kates N. Attention deficit disorder in adults. Management in primary care. Can Fam Physician. 2005 Jan;51(1):53-9.Texto completo Resumo
5. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006 Apr;163(4):716-23.Texto completo Resumo
6. Rollini M, Baud P. Pharmacological treatment of attention-deficit/hyperactivity disorder in adults [in French]. Rev Med Suisse. 2008 Jul 16;4(165):1638-43. Resumo
7. Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007 May;190:402-9.Texto completo Resumo
8. Faraone SV, Biederman J. What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Atten Disord. 2005 Nov;9(2):384-91. Resumo
9. Simon V, Czobor P, Bálint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009 Mar;194(3):204-11.Texto completo Resumo
10. Brugha T, Asherson P, Strydom A, et al. Adult psychiatric morbidity survey 2014, chapter 8: attention-deficit/ hyperactivity disorder. 2014 [internet publication].Texto completo
11. Chung W, Jiang SF, Paksarian D, et al. Trends in the prevalence and incidence of attention-deficit/hyperactivity disorder among adults and children of different racial and ethnic groups. JAMA Netw Open. 2019 Nov 1;2(11):e1914344.Texto completo Resumo
12. Ghirardi L, Brikell I, Kuja-Halkola R, et al. The familial co-aggregation of ASD and ADHD: a register-based cohort study. Mol Psychiatry. 2018 Feb;23(2):257-62.Texto completo Resumo
13. Wingo AP, Ghaemi SN. A systematic review of rates and diagnostic validity of comorbid adult attention-deficit/hyperactivity disorder and bipolar disorder. J Clin Psychiatry. 2007 Nov;68(11):1776-84. Resumo
14. de Graaf R, Kessler RC, Fayyad J, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med. 2008 Dec;65(12):835-42.Texto completo Resumo
15. Ramtekkar UP, Reiersen AM, Todorov AA, et al. Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry. 2010 Mar;49(3):217-28.Texto completo Resumo
16. Cortese S, Moreira-Maia CR, St Fleur D, et al. Association between ADHD and obesity: a systematic review and meta-analysis. Am J Psychiatry. 2016 Jan;173(1):34-43.Texto completo Resumo
17. Wilens TE, Faraone SV, Biederman J. Attention-deficit/hyperactivity disorder in adults. JAMA. 2004 Aug 4;292(5):619-23. Resumo
18. Haberstick BC, Timberlake D, Hopfer CJ, et al. Genetic and environmental contributions to retrospectively reported DSM-IV childhood attention deficit hyperactivity disorder. Psychol Med. 2008 Jul;38(7):1057-66. Resumo
19. Schultz MR, Rabi K, Faraone SV, et al. Efficacy of retrospective recall of attention-deficit hyperactivity disorder symptoms: a twin study. Twin Res Hum Genet. 2006 Apr;9(2):220-32. Resumo
20. van den Berg SM, Willemsen G, de Geus EJ, et al. Genetic etiology of stability of attention problems in young adulthood. Am J Med Genet B Neuropsychiatr Genet. 2006 Jan 5;141B(1):55-60. Resumo
21. Halperin JM, Trampush JW, Miller CJ, et al. Neuropsychological outcome in adolescents/young adults with childhood ADHD: profiles of persisters, remitters and controls. J Child Psychol Psychiatry. 2008 Sep;49(9):958-66.Texto completo Resumo
22. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021 Sep;128:789-818.Texto completo Resumo
23. Williams NM, Zaharieva I, Martin A, et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet. 2010 Oct 23;376(9750):1401-8.Texto completo Resumo
24. Demontis D, Walters RK, Martin J, et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet. 2019 Jan;51(1):63-75.Texto completo Resumo
25. Retz W, Rosler M, Kissling C, et al. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults. J Neural Transm (Vienna). 2008;115(2):323-9. Resumo
26. Stevens SE, Sonuga-Barke EJ, Kreppner JM, et al. Inattention/overactivity following early severe institutional deprivation: presentation and associations in early adolescence. J Abnorm Child Psychol. 2008 Apr;36(3):385-98. Resumo
27. Buschgens CJ, van Aken MA, Swinkels SH, et al. Differential family and peer environmental factors are related to severity and comorbidity in children with ADHD. J Neural Transm (Vienna). 2008;115(2):177-86. Resumo
28. Man KK, Chan EW, Ip P, et al. Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study. BMJ. 2017 May 31;357:j2350.Texto completo Resumo
29. Christensen J, Pedersen L, Sun Y, et al. Association of prenatal exposure to valproate and other antiepileptic drugs with risk for attention-deficit/hyperactivity disorder in offspring.JAMA Netw Open. 2019 Jan 4;2(1):e186606.Texto completo Resumo
30. Zametkin AJ, Nordahl TE, Gross M, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med. 1990 Nov 15;323(20):1361-6.Texto completo Resumo
31. Amen DG, Hanks C, Prunella J. Preliminary evidence differentiating ADHD using brain SPECT imaging in older patients. J Psychoactive Drugs. 2008 Jun;40(2):139-46. Resumo
32. Poelmans G, Pauls DL, Buitelaar JK, et al. Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. Am J Psychiatry. 2011 Apr;168(4):365-77.Texto completo Resumo
33. Kinsbourne M. Minimal brain dysfunction as a neurodevelopmental lag. Ann N Y Acad Sci. 1973 Feb 28;205:268-73. Resumo
34. Shaw P, Eckstrand K, Sharp W, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19649-54.Texto completo Resumo
35. Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019 Feb;56:14-34.Texto completo Resumo
36. Dias G, Mattos P, Coutinho G, et al. Agreement rates between parent and self-report on past ADHD symptoms in an adult clinical sample. J Atten Disord. 2008 Jul;12(1):70-5. Resumo
37. Altszuler AR, Page TF, Gnagy EM, et al. Financial dependence of young adults with childhood ADHD. J Abnorm Child Psychol. 2016 Aug;44(6):1217-29. Resumo
38. Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res. 2007;38(1):113-28. Resumo
39. Dalsgaard S, Østergaard SD, Leckman JF, et al. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet. 2015 May 30;385(9983):2190-6. Resumo
40. Guendelman MD, Ahmad S, Meza JI, et al. Childhood attention-deficit/hyperactivity disorder predicts intimate partner victimization in young women. J Abnorm Child Psychol. 2016 Jan;44(1):155-66. Resumo
41. Buitelaar NJL, Posthumus JA, Buitelaar JK. ADHD in childhood and/or adulthood as a risk factor for domestic violence or intimate partner violence: a systematic review. J Atten Disord. 2020 Jul;24(9):1203-14. Resumo
42. Ginsberg Y, Hirvikoski T, Lindefors N. Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder. BMC Psychiatry. 2010 Dec 22;10:112.Texto completo Resumo
43. Quinn PO, Madhoo M. A review of attention-deficit/hyperactivity disorder in women and girls: uncovering this hidden diagnosis. Prim Care Companion CNS Disord. 2014;16(3).Texto completo Resumo
44. Fuller-Thomson E, Lewis DA, Agbeyaka SK. Attention-deficit/hyperactivity disorder casts a long shadow: findings from a population-based study of adult women with self-reported ADHD. Child Care Health Dev. 2016 Nov;42(6):918-927. Resumo
45. Hosain GM, Berenson AB, Tennen H, et al. Attention deficit hyperactivity symptoms and risky sexual behavior in young adult women. J Womens Health (Larchmt). 2012 Apr;21(4):463-8. Resumo
46. DuPaul GJ, Stoner G. ADHD in the schools: assessment and intervention strategies. New York, NY: Guilford Press; 1994.
47. Kessler RC, Adler LA, Gruber MJ, et al. Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16:52-65.Texto completo Resumo
48. Youssef NA, Ege M, Angly SS, et al. Is obstructive sleep apnea associated with ADHD? Ann Clin Psychiatry. 2011 Aug;23(3):213-24. Resumo
49. Crunelle CL, van den Brink W, Moggi F, et al. International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder. Eur Addict Res. 2018;24(1):43-51.Texto completo Resumo
50. Wilens TE. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. J Clin Psychiatry. 2007;68 (Suppl 11):4-8. Resumo
51. Fischer M, Barkley RA, Smallish L, et al. Hyperactive children as young adults: driving abilities, safe driving behavior, and adverse driving outcomes. Accid Anal Prev. 2007 Jan;39(1):94-105. Resumo
52. Mannuzza S, Klein RG, Moulton JL 3rd. Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records. Psychiatry Res. 2008 Sep 30;160(3):237-46.Texto completo Resumo
53. Conners CK. Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder. Pediatr Clin North Am. 1999 Oct;46(5):857-70. Resumo
54. Audenaert K, Jansen HM, Otte A, et al. Imaging of mild traumatic brain injury using 57Co and 99mTc HMPAO SPECT as compared to other diagnostic procedures. Med Sci Monit. 2003 Oct;9(10):MT112-7.Texto completo Resumo
55. World Health Organization. ICD-11 International statistical classification of diseases and related health problems, 11th revision Geneva: WHO; 2022.Texto completo
56. Barkley RA, ed. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 3rd ed. New York, NY: Guilford Press; 2006.
57. Brown TE. The Brown attention deficit disorder scales. San Antonio, TX: Psychological Corporation; 1996.
58. Wender PH. Attention-deficit hyperactivity disorder in adults. New York, NY: Oxford University Press; 2001.
59. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993 Jun;150(6):885-90. Resumo
60. Das D, Vélez JI, Acosta MT, et al. Retrospective assessment of childhood ADHD symptoms for diagnosis in adults: validity of a short 8-item version of the Wender-Utah Rating Scale. Atten Defic Hyperact Disord. 2016 Dec;8(4):215-23. Resumo
61. Searight HR, Burke JM, Rottnek F. Adult ADHD: evaluation and treatment in family medicine. Am Fam Physician. 2000 Nov 1;62(9):2077-86.Texto completo Resumo
62. Barkley RA, Brown TE. Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders. CNS Spectr. 2008 Nov;13(11):977-84. Resumo
63. Taylor A, Deb S, Unwin G. Scales for the identification of adults with attention deficit hyperactivity disorder (ADHD): a systematic review. Res Dev Disabil. 2011 May-Jun;32(3):924-38. Resumo
64. Hirvikoski T, Waaler E, Lindström T, et al. Cognitive behavior therapy-based psychoeducational groups for adults with ADHD and their significant others (PEGASUS): an open clinical feasibility trial. Atten Defic Hyperact Disord. 2015 Mar;7(1):89-99.Texto completo Resumo
65. Hirvikoski T, Lindström T, Carlsson J, et al. Psychoeducational groups for adults with ADHD and their significant others (PEGASUS): A pragmatic multicenter and randomized controlled trial. Eur Psychiatry. 2017 Jul;44:141-52.Texto completo Resumo
66. Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018 Sep;5(9):727-38.Texto completo Resumo
67. Spencer TJ, Adler LA, Meihua Qiao, et al. Validation of the adult ADHD investigator symptom rating scale (AISRS). J Atten Disord. 2010 Jul;14(1):57-68. Resumo
68. Medicines and Healthcare products Regulatory Agency. Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations. Sep 2022 [internet publication].Texto completo
69. Moran LV, Ongur D, Hsu J, et al. Psychosis with methylphenidate or amphetamine in patients with ADHD. N Engl J Med. 2019 Mar 21;380(12):1128-38.Texto completo Resumo
70. Hollis C, Chen Q, Chang Z, et al. Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study. Lancet Psychiatry. 2019 Aug;6(8):651-8.Texto completo Resumo
71. Hodgkins P, Shaw M, McCarthy S, et al. The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter? CNS Drugs. 2012 Mar 1;26(3):245-68. Resumo
72. Schneider-Thoma J, Efthimiou O, Bighelli I, et al. Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis. Lancet Psychiatry. 2019 Sep;6(9):753-65. Resumo
73. Verbeeck W, Bekkering GE, Van den Noortgate W, et al. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2017 Oct 2;(10):CD009504.Texto completo Resumo
74. Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry. 2010 Jun;71(6):754-63. Resumo
75. Kendall T, Taylor E, Perez A, et al; Guideline Development Group. Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. BMJ. 2008 Sep 24;337:a1239. Resumo
76. Jensen CM, Amdisen BL, Jørgensen KJ, et al. Cognitive behavioural therapy for ADHD in adults: systematic review and meta-analyses. Atten Defic Hyperact Disord. 2016 Mar;8(1):3-11. Resumo
77. Sollitto RJ. Implant arthroplasty: still a consideration. Clin Podiatr Med Surg. 1989 Jan;6(1):149-60.Texto completo Resumo
78. Young Z, Moghaddam N, Tickle A. The efficacy of cognitive behavioral therapy for adults with ADHD: a systematic review and meta-analysis of randomized controlled trials. J Atten Disord. 2020 Apr;24(6):875-88.Texto completo Resumo
79. Solanto MV, Marks DJ, Wasserstein J, et al. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry. 2010 Aug;167(8):958-68.Texto completo Resumo
80. Hirvikoski T, Waaler E, Alfredsson J, et al. Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. Behav Res Ther. 2011 Mar;49(3):175-85. Resumo
81. Zhang J, Díaz-Román A, Cortese S. Meditation-based therapies for attention-deficit/hyperactivity disorder in children, adolescents and adults: a systematic review and meta-analysis. Evid Based Ment Health. 2018 Aug;21(3):87-94.Texto completo Resumo
82. Adamou M, Asherson P, Arif M, et al. Recommendations for occupational therapy interventions for adults with ADHD: a consensus statement from the UK adult ADHD network. BMC Psychiatry. 2021 Feb 4;21(1):72.Texto completo Resumo
83. Katzman MA, Bilkey TS, Chokka PR, et al. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry. 2017 Aug 22;17(1):302.Texto completo Resumo
84. Lopez PL, Torrente FM, Ciapponi A, et al. Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2018 Mar 23;(3):CD010840.Texto completo Resumo
85. Emilsson B, Gudjonsson G, Sigurdsson JF, et al. Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. BMC Psychiatry. 2011;11:116.Texto completo Resumo
86. Boesen K, Paludan-Müller AS, Gøtzsche PC, et al. Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2022 Feb 24;2:CD012857.Texto completo Resumo
87. American Psychiatric Association. Guideline watch (March 2013): Practice guideline for the treatment of patients with obsessive-compulsive disorderTexto completo
88. Pompoli A, Furukawa TA, Imai H, et al. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis. Cochrane Database Syst Rev. 2016 Apr 13;4:CD011004.Texto completo Resumo
89. Rodrigues MF, Nardi AE, Levitan M. Mindfulness in mood and anxiety disorders: a review of the literature. Trends Psychiatry Psychother. 2017 Jul-Sep;39(3):207-15.Texto completo Resumo
90. Nasser A, Liranso T, Adewole T, et al. A phase Ill, randomized, placebo-controlled trial to assess the efficacy and safety of once-daily SPN-812 (viloxazine extended-release) in the treatment of attention-deficit/hyperactivity disorder in school-age children. Clin Ther. 2020 Aug;42(8):1452-66.Texto completo Resumo
91. Nasser A, Liranso T, Adewole T, et al. A phase 3, placebo-controlled trial of once-daily viloxazine extended-release capsules in adolescents with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2021 Jul-Aug 01;41(4):370-80.Texto completo Resumo
92. Nasser A, Liranso T, Adewole T, et al. A phase 3 placebo-controlled trial of once-daily 400-mgand 600-mg SPN-812 (viloxazine extended-release) in adolescents with ADHD.Psychopharmacol Bull. 2021 Mar 16;51(2):43-64.Texto completo Resumo
93. Nasser A, Liranso T, Adewole T, et al. Once-daily SPN-812 200 and 400 mg in the treatment ofADHD in school-aged children: a phase III randomized, controlled trial. Clin Ther. 2021Apr;43(4): 684-700Texto completo Resumo
94. Lugo J, Fadeuilhe C, Gisbert L, et al. Sleep in adults with autism spectrum disorder and attention deficit/hyperactivity disorder: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2020 Sep;38:1-24.Texto completo Resumo
95. Septier M, Stordeur C, Zhang J, et al. Association between suicidal spectrum behaviors and Attention-Deficit/Hyperactivity Disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2019 Aug;103:109-18.Texto completo Resumo
96. Chang Z, Quinn PD, Hur K, et al. Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes. JAMA Psychiatry. 2017 Jun 1;74(6):597-603.Texto completo Resumo
97. Jerome L, Habinski L, Segal A. Attention-deficit/hyperactivity disorder (ADHD) and driving risk: a review of the literature and a methodological critique. Curr Psychiatry Rep. 2006 Oct;8(5):416-26. Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal